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Branching tubulogenesis of the ureteric bud is critically important for
kidney development. Recent findings using three-dimensional cell culture
systems for in vitro branching tubulogenesis are likely to shed light on the
mechanisms of ureteric bud morphogenesis. Here, we try to unify these
findings with those obtained using genetic approaches and organ culture
of the embryonic kidney into a working model of ureteric bud branching
tubulogenesis. It appears that the balance between branching tubulogen-
esis facilitating growth factors such as epidermal growth factor receptor
ligands, hepatocyte growth factor, insulin-like growth factors, and inhibi-
tory growth factors such as transforming growth factor beta family
members may regulate branching morphogenesis. Growth factors induce
epithelial cell proliferation, migration, and modulate the expression of a
variety of proteins. Downstream in the growth factor-mediated tubulogen-
esis pathway, extracellular proteases, protease inhibitors, extracellular
matrix proteins, and integrins are likely to act as effectors and regulators
of branching tubulogenesis. Discussed in some detail are the relevance of
insights gleaned from in vitro models of branching tubulogenesis to
congenital urogenital abnormalities, cystic kidney diseases, oligone-
phropathies and hypertension, tubular cell regeneration after injury, and
tubular engineering.
In mammals, development of the permanent kidney
(metanephros) begins when the tip of the mesonephric duct
(Wolffian duct), known as the ureteric bud, invades the
undifferentiated mesenchyme [1, 2]. The ureteric bud
forms branching tubules that eventually differentiate into
the collecting ducts and the ureter down to its insertion in
the bladder trigone. At the same time, cells of the meta-
nephric mesenchyme differentiate into epithelial cells that
will eventually develop into the nephron. These two em-
bryonic structures, ureteric bud and metanephric mesen-
chyme, mutually induce each other. This induction process
has been the subject of intense investigation in recent years.
A key question revolves around the identity of the signaling
molecules and their mode of transmission.
The present review focuses on the molecular mecha-
nisms underlying ureteric bud branching morphogenesis
induced by the metanephric mesenchyme and will address:
(1) experimental systems used to analyze the mechanisms
of branching morphogenesis, and (2) molecules likely to
play important roles in the process (such as, soluble factors,
extracellular matrix, proteases, and protease inhibitors).
Results obtained from the study of ureteric bud branching
morphogenesis may have implications for many aspects of
kidney disease, such as congenital urogenital abnormalities
and renal cystic disease, “oligonephropathy” (which may be
an important cause of hypertension), and tubular regener-
ation following acute renal failure. Moreover, the simple
cell culture models used to study tubulogenesis can be
viewed as a basic technology supporting tubular engineer-
ing and potential artificial renal replacement therapy. Thus,
studies on ureteric branching have both fundamental and
applied relevance.
METHODS FOR STUDYING URETERIC BUD
BRANCHING MORPHOGENESIS
Several approaches have been used to study branching
morphogenesis of the ureteric bud. Particularly interesting
have been in vivo studies using genetically manipulated
mice [3–5]. The effects of both a specific perturbation and
overexpression of particular genes on the entire process of
kidney development have been analyzed. While successful
genetic studies allow one to unambiguously ascribe a
particular phenotype to the action of a specific gene,
biochemical and other methods are needed to define the
molecular mechanism by which a specific gene product acts
in kidney development, and this is difficult to do in the
whole animal.
A second approach involves embryonic kidney organ
culture, an in vitro technique that has been used for many
years [6]. Kidneys dissected from mouse or rat embryos are
placed on top of filters and grown in vitro under rigorously
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defined conditions (Fig. 1) [7, 8]. Except for vascular
development, cultured kidneys grow like their in vivo
counterparts. The roles of particular gene products are
then deduced by adding soluble factors or their inhibitors
to the organ culture. Unlike the cell culture models de-
scribed later, organ culture has the advantage of using
“real” kidneys. On the other hand, complexity of the
developing kidney makes detailed study of one specific
process (such as ureteric bud branching morphogenesis)
difficult. Moreover, growth of the cultured kidney is often
affected more by dissection technique than by the specific
treatment. In addition, the delivery of reagents to a specific
structure can be difficult [9]. Nevertheless, the method
serves as a useful complement to genetic and cell culture
studies.
A third approach uses cell culture models. When certain
kidney-derived epithelial cells are suspended in gels com-
posed of extracellular matrix, it is possible to observe the
morphogenetic process (that is, tubule branching or cyst
formation) starting from a single epithelial cell or a genet-
ically homogenous epithelial cell clump, which appear to
mimic similar in vivo events (Fig. 2) [10, 11]. This simple,
highly controllable model makes it possible to analyze such
morphogenetic processes in detail. The major drawback of
this technique is the risk of oversimplification; it may not be
possible to extrapolate certain results obtained from cell
culture studies to in vivo kidney development. However, at
the present time it is the simplest system available to study
the complicated morphogenetic events of kidney develop-
ment.
These cell culture systems can be set up in several ways
(Fig. 3). Purified growth factors can be added to kidney-
derived epithelial cells grown in three-dimensional extra-
cellular matrix gels. Madin-Darby canine kidney (MDCK),
murine inner medullary collecting duct (mIMCD) 3, and
ureteric bud (UB) cells have all been used for this purpose
[10, 12–16]. Alternatively, conditioned medium derived
from mesenchymal cell lines, such as Swiss 3T3 cells or
metanephric mesenchyme-derived BSN cells [16], can be
employed to stimulate kidney-derived epithelial cells in
three-dimensional culture. Finally, the embryonic kidney or
isolated metanephric mesenchyme from gestational day 11
to 14 mouse embryos are cocultured with kidney-derived
epithelial cells grown in three-dimensional matrix gels. It is
now evident from these model systems that, at least in vitro,
several soluble factors can induce epithelial cell branching
tubulogenesis in three-dimensional extracellular matrix
gels, in which there appears to be no cell-to-cell contact
between epithelial and mesenchymal cells [14–16].
GROWTH FACTORS INVOLVED IN BRANCHING
TUBULOGENESIS
Possible “tubulogenic” growth factors
Hepatocyte growth factor. Several years ago, it was found
that MDCK cells undergo branching tubulogenesis when
cultured in type 1 collagen in the presence of hepatocyte
growth factor (HGF) [17]. The MDCK tubules induced by
HGF have lumens and retain epithelial cell polarity [12].
Embryonic kidney or isolated metanephric mesenchyme, in
the absence of direct contact, can also induce similar
morphogenetic changes in MDCK cells grown in collagen
Fig. 1. Serum-free culture of mouse embryonic
kidney. Embryonic day 11.5 mouse kidney was
dissected and placed on the filter. The picture
was taken on third day of culture.
Abbreviations are: UB, ureteric bud; MM,
metanephric mesenchyme. Bar 5 50 mm.
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gels [18]. The application of neutralizing anti-HGF anti-
bodies to the MDCK cell-embryonic kidney coculture
system suggests that the major MDCK cell morphogen
secreted by embryonic kidney is HGF [18]. In addition,
anti-HGF antibodies inhibit growth of embryonic kidney
cultured in serum-free, defined medium [18]. Thus, it
seemed reasonable to assume that HGF secreted from
metanephric mesenchyme mediates the signal that induces
kidney epithelial cell branching tubulogenesis. However,
genetically engineered mice lacking HGF or its receptor,
c-met, appear to have grossly normal kidney development
up to gestational day 14, at which point they die from liver
failure [19, 20]. Although it is possible that HGF exerts its
tubulogenic action after day 14, these genetic data raise the
possibility that other growth factors are important in col-
lecting system development. It may be that MDCK cells do
not accurately reflect ureteric bud behavior in terms of
responsiveness to growth factors, since MDCK cells re-
spond almost exclusively to HGF, while this might not be
the case for the ureteric bud.
Epidermal growth factor receptor ligands. In support of the
notion described above, an epithelial cell line derived from
descendants of ureteric bud, mIMCD3 cells, form branch-
ing tubules in response to ligands of the epidermal growth
factor (EGF) receptor, including EGF and transforming
growth factor (TGF)-a, as well as HGF [14, 15]. In the
presence of embryonic kidney, mIMCD3 cells grown in
collagen gels form branching tubules, just as observed with
MDCK cells. In contrast to MDCK cells, the addition of
neutralizing anti-HGF antibodies to the embryonic kidney-
mIMCD3 cell coculture system has little effect on
mIMCD3 cell tubulogenesis [14, 15]. However, mIMCD3
cell tubulogenesis is significantly inhibited by a “specific”
EGF receptor tyrosine kinase inhibitor, tyrphostin AG1478.
Furthermore, embryonic epithelial cells from c-met knock-
out mice form early tubule-like structures in the presence
of EGF receptor ligands such as TGF-a [15, 21]. In
addition, TGF-a has been shown to facilitate embryonic
kidney growth in organ culture, and addition of neutralizing
anti-TGF-a antibodies to embryonic kidney organ culture
inhibits growth [22]. However, the absence of TGF-a
expression does not result in a defective kidney phenotype
[23, 24]. Perhaps other ligands for EGF receptor present in
the embryonic kidney (such as, heparin binding EGF)
compensate for the loss of TGF-a. In contrast to single
ligand knockout (TGF-a knockout) mice, EGF receptor
knockout mice with certain genetic backgrounds develop
dilated collecting ducts and impaired renal function [25].
Taken together, these data suggest that multiple EGF
receptor ligands, each capable of activating a single recep-
tor, play an important role in collecting duct development.
Insulin-like growth factor. Insulin-like growth factor
(IGF) has two isoforms, IGF-1 and IGF-2, both of which
are present in the embryonic kidney [26]. Application of
extrinsic IGFs stimulates embryonic kidney growth in organ
culture, and neutralizing anti-IGF antibodies inhibit it [26].
Moreover, the IGF-1 receptor is highly expressed in the
ureteric bud, and interference with expression by antisense
Fig. 2. Three-dimensional culture of murine
inner medullary collecting duct (mIMCD)3
cells (A, B) and ureteric bud (UB) cells (C, D).
The mIMCD3 cells were grown for 48 hours in
Matrigel (A) or Type 1 collagen gel (B) in the
presence of 3T3 cell conditioned medium
(contains HGF). UB cells were grown for five
days in Matrigel (C) or in Type 1
collagen/Matrigel (80:20) mixture (D) in the
presence of BSN cell conditioned medium and
0.5% serum. Bars 5 25 mm.
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oligonucleotides in embryonic kidney organ culture results
in decreased kidney size and disorganized ureteric bud
branching [27]. These data are consistent with three-
dimensional cell culture studies of cells derived from
gestational day 11.5 ureteric bud (UB cells). When grown
in collagen gels, these cells undergo early events in tubu-
logenesis (process and multicellular cord formation) in
response to IGF-1 [16]. As with HGF, IGF-1 or IGF-2
knockout mice show no apparent disruption of ureteric bud
branching morphogenesis [28–30], even though in vitro
data suggest the importance of IGFs in ureteric bud
branching morphogenesis.
Glial-cell-line-derived neurotrophic factor. Glial-cell-line-
derived neurotrophic factor (GDNF) has recently been
identified as a ligand for the receptor tyrosine kinase, c-ret
[31–34]. Agenesis or severe hypogenesis of the kidney is
observed in c-ret knockout mice [35]. A similar phenotype
is seen in GDNF knockout mice [36–38]. The tips of
ureteric buds express c-ret [39], and metanephric mesen-
chyme surrounding the tips of ureteric bud expresses
GDNF [40]. Addition of exogenous GDNF in organ culture
facilitates kidney growth, and addition of neutralizing anti-
GDNF antibodies disrupts ureteric bud branching morpho-
genesis [33]. However, in three-dimensional cultures of UB
cells, GDNF does not induce tubulogenesis [16]. Though
c-ret mRNA is detectable by RT-PCR in UB cells, these
cells may not express enough c-Ret at the cell surface. It is
also possible that direct cell-to-cell contact, which is absent
in three-dimensional cultures, is required for GDNF ac-
tion. Another explanation for the lack of GDNF morpho-
genetic action in the cell culture model is that GDNF is
largely an early ureteric bud survival factor rather than a
morphogen. Perhaps GDNF is important in mediating
mesenchymal signals to the ureteric bud; however, the
exact mechanism of its action remains to be elucidated.
Ligand(s) for c-ros. c-ros is the mammalian homologue of
sevenless, a Drosophilia gene involved in eye morphogenesis
[41]. In mice, c-ros expression is localized to the tip of
ureteric bud, like c-ret. c-ros antisense oligonucleotides
inhibit ureteric bud branching morphogenesis in organ
Fig. 3. Schematic representation of three-dimensional cell culture system. Kidney derived epithelial cells suspended in extracellular matrix gel (either
Type 1 collagen or mixture of Type 1 collagen and Matrigel) form branching tubular structures when cultured with embryonic day 13 to 14 kidneys or
the isolated metanephric mesenchyme. The soluble factors secreted from embryonic kidneys induce branching tubulogenesis. Purified single growth
factors induce similar morphogenetic changes in kidney epithelial cells grown in three-dimensional culture, though addition of serum is often required,
especially for prolonged culture. There is substantial difference in growth factor responsiveness among MDCK, mIMCD3 and UB cells (see text).
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culture experiments [42]. Unlike c-ret, c-ros knockout mice
show normal kidney development [43]. Identification of its
ligand(s) is the next step toward understanding the role of
the c-ros in ureteric bud branching morphogenesis.
Transforming growth factor-b superfamily. Transforming
growth factor (TGF)-b and members of its superfamily
have many effects on development [44]. In contrast to the
factors discussed above, which facilitate branching tubulo-
genesis, TGF-b generally inhibits epithelial cell growth
[45]. In organ culture, addition of exogenous TGF-b inhib-
its the growth of the embryonic kidney, and addition of
neutralizing anti-TGF-b1 antibodies facilitates growth [46].
In three-dimensional culture of mIMCD3 cells, TGF-b
alone has no obvious morphogenetic effects. However, in
the presence of a factor that facilitates branching tubulo-
genesis (such as HGF), TGF-b (0.02 to 2 ng/ml) inhibits
branching events but not tubulogenesis [47]. Thus, long
non-branching tubules form. This result suggests that the
balance of branch-facilitating factors and branch-inhibitory
factors (such as the TGF-bs) is important in the regulation
of branching events. TGF-b1, -b2, and -b3 exert similar
inhibitory effects on branching of mIMCD3 cells, suggest-
ing functional redundancy [47]. Nevertheless, the temporal
and spatial distribution of TGF-b isoforms is not identical,
suggesting the existence of functional distinctions among
the isoforms [48]. Of the three isoforms, only TGF-b2
knockout mice have a defective kidney phenotype [49].
Other members of the TGF-b superfamily may have
similar actions. Activin, for example, inhibits collecting
duct development in vitro [50]. Another TGF-b superfamily
member is bone morphogenic protein (BMP7). BMP7
knockout mice have no or very small, disorganized kidneys
[51, 52]. It appears that initial ureteric bud branching
occurs, but further kidney development does not; thus,
BMP7 might not act directly on ureteric bud branching
morphogenesis. Rather, it might be an important factor for
the differentiation of metanephric mesenchyme cells so
that they can induce further ureteric bud branching mor-
phogenesis, perhaps through the secretion of some of the
tubulogenic growth factors discussed above.
Novel growth factor(s). Not all of the growth factors
required for ureteric bud branching morphogenesis have
been identified. BSN cells, probably derived from gesta-
tional day 11.5 kidney mesenchyme [16], make growth
factors including HGF, EGF receptor ligands, and TGF-b.
When UB cells are cultured in collagen gels, BSN cell
conditioned medium (BSN-CM) can induce full-fledged
UB cell tubulogenesis in the presence of minimal serum.
Early (up to three days) UB cell tubulogenic activity of
BSN-CM is largely accounted for by HGF and EGF
receptor ligands. However, at a later time point (more than
five days), inhibition of HGF and EGFR abolishes only 40
to 50% of BSN-CM induced UB cell tubulogenesis. Also,
neither purified HGF nor EGF receptor ligands supports
sustained UB cell tubulogenesis while BSN-CM does. Even
a mixture of growth factors likely to be important for
tubulogenesis in vitro and in vivo (that is, HGF, TGF-a,
IGF-1, and GDNF) cannot match the tubulogenic activity
of BSN-CM, and none of these alone or in combination can
induce the formation of structures with lumens seen with
treatment by BSN-CM. Thus, BSN-CM contains novel
tubulogenic factors necessary for sustained morphogenesis
and lumen formation.
Redundancy of growth factor action
We have discussed several candidate growth factors
involved in ureteric bud branching tubulogenesis. It is not
known whether all these growth factors are necessary to
carry out ureteric bud branching tubulogenesis. Different
growth factors may be needed at different times. For
example, among EGFR ligands, EGF is expressed in the
kidney mainly after birth, while TGF-a is expressed in the
embryonic kidney. Some of the growth factors may also be
redundant in this particular context. Evidence for this
hypothesis includes: (1) the failure to demonstrate a defec-
tive kidney phenotype in many of the single growth factor
knockout mice; (2) the lack of obvious morphological
differences between the early tubule-like structures in-
duced by different growth factors in the UB cell three-
dimensional culture model [16]; (3) demonstration in co-
culture experiments of embryonic kidney with either UB or
mIMCD3 cells that inhibition of either HGF or EGFR is
not sufficient to abolish tubulogenesis [15, 16]; and (4)
demonstration that cells lacking c-met can undergo mor-
phogenesis in response to other growth factors [21]. Never-
theless, the term redundancy probably deserves to be used
with some caution; subtle defects in nephrogenesis and in
vitro tubulogenesis may become evident with more detailed
analysis or under different conditions.
INTRACELLULAR PATHWAYS INVOLVED IN
GROWTH FACTOR-INDUCED TUBULOGENESIS
Mechanisms of growth factor action
While it is clear that one or more growth factors are
likely to play a key role in ureteric bud branching morpho-
genesis, it is not evident how these growth factors coordi-
nate the expression of genes necessary for the three-
dimensional morphogenetic changes leading to branching
tubulogenesis. Obviously, cells must proliferate. Most
“growth” factors induce proliferation. Cells must also
change their shape in the direction of tubule formation as
they form branching processes and multicellular cords.
These cell shape changes involve tremendous cytoskeleton
reorganization. In addition, as tubule formation occurs,
cells must also digest/change the extracellular matrix sur-
rounding them. Expression of genes for extracellular pro-
teases and their inhibitors, as well as extracellular matrix
proteins and integrins, will be altered. As the nascent
tubule with lumen develops, cells must pack themselves
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adjacent to other cells and polarize. Dissociated intercellu-
lar junctions must be reestablished.
Intracellular signal transduction pathways involved in
tubulogenesis in vitro
Following the activation of growth factor receptors, it is
likely that many intracellular signaling molecules initiate
multiple signal cascades eventually leading to tubulogen-
esis. The coordination of these events is far from clear.
Nevertheless, some insight can be gleaned from studies of
the HGF/c-Met axis [53, 54]. When c-Met is activated by
HGF, it forms a homodimer, and tyrosine residues are auto
(or cross) phosphorylated. These phosphotyrosines become
binding sites for proteins such as c-Src, phosphoinositide-3
kinase (PI3 kinase), Grb2, and phospholipase Cg (PLCg)
that mediate downstream signals. Among these, the PI3
kinase pathway appears to be important in tubulogenesis.
When the PI3 kinase pathway is inhibited by wortmannin,
HGF-induced chemotaxis and tubulogenesis is inhibited in
MDCK and mIMCD3 cells, with relatively little effect on
proliferation [13].
Recently it has been demonstrated that the docking
protein Gab1 is specifically associated with c-Met and
transduces the chemotactic and morphogenetic signal from
c-Met [55]. Moreover, MDCK cells transfected with Gab1
scatter and undergo branching morphogenesis in the ab-
sence of HGF. Thus, at least in MDCK cells, Gab1
activation is necessary and sufficient for cell scattering and
morphogenesis. In another epithelial cell line, A431, Gab1
is involved in PI3 kinase activation by the EGF receptor
[56]. Since Gab1 has several binding sites for proteins that
have SH2 (Src homology2) or SH3 domains, it is possible
that PI3 kinase and other proteins involved in tubulogen-
esis bind to Gab1 and transmit the signal instead of directly
binding to c-Met.
It appears that tubulogenic growth factors ultimately act
on junctional proteins and cytoskeletal proteins [54]. In the
HGF-induced MDCK tubulogenesis model, mutation of b
catenin inhibits tubulogenesis [57]. Catenins are thought to
mediate the interaction between adherens junction pro-
teins, such as E-cadherin and cytoskeletal proteins. Like-
wise, HGF-induced LLC-PK1 cell tubulogenesis is inhibited
by mutation of ezrin, which is also thought to mediate the
interaction between membrane proteins and the actin
cytoskeleton [58]. Both b catenin and ezrin are phosphor-
ylated at a tyrosine residue following HGF treatment [59,
60]. Thus, HGF appears to exert its action by modulating
the function of “bridging molecules” between membrane
and cytoskeleton, both of which play critical roles in
morphogenesis and motility (Fig. 4).
EXTRACELLULAR MOLECULES INVOLVED IN
REGULATION OF GROWTH FACTOR-INDUCED
TUBULOGENESIS
When MDCK cells are plated on type 1 collagen, tubule-
like structures do not form even in the presence of HGF.
MDCK cells must be suspended in collagen gels to undergo
tubulogenesis. The ability of cells to interact with the matrix
environment is an important determinant of tubulogenesis
and branching morphogenesis. Among the candidate mol-
ecules likely to be important in matrix modulation are
extracellular proteases, extracellular matrix proteins, and
integrins. These molecules, together with growth factors,
regulate the morphogenetic processes (Fig. 5).
Extracellular matrix-degrading proteases
Cells must digest the surrounding extracellular matrix for
tubulogenesis to occur. Several lines of evidence support an
essential role for extracellular proteases in tubulogenesis.
First, when mIMCD3 cells are cultured in collagen gels, the
metalloprotease inhibitor 1,10-phenanthroline abolishes
tubulogenesis induced by TGF-a and other EGFR ligands
[15]. Second, EGFR ligands up-regulate matrix metallopro-
tease (MMP-1) mRNA expressed in mIMCD3 cells under-
going tubulogenesis. A similar result has been obtained in
HGF-induced MDCK cell tubulogenesis [61]. Third, when
HGF and TGF-b together induce long, non-branching
tubules in mIMCD3 cells grown in collagen gels, the ratio
of mRNAs for proteases (MMP-1 and urokinase) and
protease inhibitors (tissue inhibitor of metalloproteases
and plasminogen activator inhibitor) are altered [47]. Thus,
in cell culture models tubulogenic growth factors appear to
exert at least part of their action by changing the expression
of proteases and/or their inhibitors.
Involvement of MMPs in ureteric bud branching mor-
phogenesis has also been shown in organ culture [62]. In
cultured day 11 embryonic kidney, inhibition of MMP-9,
but not MMP-2 blocks ureteric bud branching morphogen-
esis. When examined by immunostaining, MMP-2 and
MMP-9 appear to be secreted from mesenchymal cells.
This raises the possibility that proteases may be one of the
mesenchymal-derived molecules necessary for ureteric bud
branching morphogenesis. Whether mesenchymal derived
proteases are under control of growth factors remains to be
determined.
Extracellular matrix and integrins
Extracellular matrix composition clearly affects branch-
ing tubulogenesis in cell culture models. As shown in
Figure 2, both mIMCD3 and UB cells form multicellular
cysts when they are cultured in Matrigel, a basement
membrane matrix extracted from EHS tumor cell line, even
in the presence of tubulogenic growth factors. Although it
is not as dramatic as Matrigel, several extracellular matrix
proteins, some of which are components of Matrigel,
modulate HGF-induced MDCK cell tubulogenesis in vitro.
Collagen I, laminin, fibronectin, and entactin facilitate
tubulogenesis, while collgen IV, vitronectin, and heparan
sulfate proteoglycan inhibit it [11]. One component of
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basement membranes, proteoglycans, is likely to be impor-
tant for tubulogenesis. For example, inhibitors of proteo-
glycan synthesis can perturb kidney development in organ
culture [65, 66]. Inhibition of proteoglycan synthesis leads
to loss of Wnt-11 expression at the tip of the ureteric bud
[67]. Although its exact function is yet to be defined,
Wnt-11’s localization at the tip of the ureteric bud suggests
a role in ureteric bud branching morphogenesis. Together,
these data provide evidence that the composition of the
ECM is critically important in the modulation of morpho-
genesis.
The cell “senses” the extracellular matrix through cell
receptors called integrins. Perturbation of certain integrin
function can also inhibit ureteric bud branching morpho-
genesis. For example, a3 integrin knockout mice show
decreased branching of kidney collecting ducts as well as of
lung bronchi [69]. In the MDCK cell collagen gel culture,
cells transfected with antisense a2 b1 integrin RNA fail to
form branching tubules in response to HGF and also show
increased apoptosis [70]. Because a2b1 integrin is a recep-
tor for type 1 collagen, this result supports previous findings
that signals from surrounding extracellular matrix are im-
portant in MDCK cell morphogenesis and survival. Re-
cently, a8 b1 integrin knockout mice were found to have a
defect in ureteric bud branching morphogenesis [71]. Al-
though ligands for a8 b1 integrin have yet to be defined, it
is expected that they are in close contact with ureteric buds.
Thus, extracellular matrix proteins and their integrin recep-
tors regulate the morphogenetic processes much like
growth factors and their receptors.
From all the data presented above, it is clear that ureteric
bud branching morphogenesis is a complicated process,
which involves a complex interplay of molecules such as
growth factors, extracellular matrix, integrins, proteases,
and protease inhibitors.
Applications of tubulogenesis research
Aberrant UB branching morphogenesis can result in
malformations of the urinary collecting system that lead to
a wide range of kidney disease [2]. In addition, factors that
stimulate and modulate branching tubulogenesis are likely
to play critical roles in repair of tubules injured by ischemia
or toxin. Those factors are also likely to be important for
the engineering of artificial tubules. In this section we focus
Fig. 4. Schematic model of hepatocyte growth factor (HGF) intracellular signaling pathways involved in tubulogenesis. HGF receptor (c-Met) is
associated with docking protein Gab1 following ligand activation. Gab1 transmits the signal to other intracellular molecules yet to be defined completely.
Finally, the signals are transmitted to “bridging proteins” between membrane and cytoskeleton such as b catenin and ezrin.
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on implications of in vitro tubulogenesis models beyond the
field of kidney development (Fig. 6).
Developmental disorders of the kidney. Renal agenesis can
be due to failure of the ureteric bud to develop from the
mesonephric duct [72]. In the case of bilateral renal
agenesis, which is often accompanied by extensive anoma-
lies in other organ systems, it is likely that there is a
disruption of “master” regulatory genes critical for normal
development of the kidney and other organs. In contrast,
unilateral renal agenesis, which is often asymptomatic, may
result from defective local control of outgrowth and
branching of the ureteric bud. One possibility is the lack of
certain factors produced by the mesenchyme that induce
mesonephric epithelial cells to form the ureteric bud.
Another possibility is the existence of intrinsic defects in a
group of mesonephric epithelial cells normally “pro-
grammed” to become ureteric bud. In addition to defects in
initial ureteric bud development, poor development and/or
maintenance of branching tubular structures derived from
the ureteric bud are likely to be responsible for a wide
variety of renal dysplasia. It seems reasonable to expect
that some of these dysplasias will be due to aberrations in
growth factor pathways important in in vitro tubulogenesis
and/or abnormalities in the effectors of tubulogenesis (pro-
teases, matrix, integrins) or their regulators.
Nephron number. Based on studies that link adult essen-
tial hypertension to intrauterine growth retardation and/or
low birth weight, it has been hypothesized that low nephron
number (oligonephropathy) might be an important cause of
hypertension [73, 74]. Indirect support for this hypothesis
comes from kidney transplantation follow-up studies, which
show that one of the non-immunological determinants of
chronic graft failure is a small kidney relative to recipient
body size [75]. If so, it is important to identify the factors
affecting nephron number. As mentioned previously, the
ureteric bud induces nephrons from metanephric mesen-
chyme cells at its branching tips. Since the ureteric bud
branches about 15-20 times during kidney development and
Fig. 5. Cellular model of tubulogenesis. As discussed in the text, interplay of growth factors, extracellular matrix proteins, integrins and extracellular
proteases/protease inhibitors regulates morphogenetic processes.
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since each tip induces nephrons (if one makes some
simplifying assumptions about mechanisms of collecting
system development), a 2% decrease in the “efficiency” of
branching manifests itself in roughly half the “normal”
number of nephrons after 20 generations of branching.
Furthermore, administration of exogenous HGF [80, 81],
EGF [82, 83] or IGF [84] enhances kidney recovery follow-
ing a variety of insults. All these molecules induce some
degree of morphogenesis in UB cells [16]. Thus, ureteric
bud branching events are an important determinant of
nephron number. Growth factors, proteases and their
inhibitors, extracellular matrix proteins and their integrin
receptors, which regulate ureteric bud branching morpho-
genesis, should therefore also regulate nephron number.
Since there appears to be a genetic predisposition to low
birth weight, we speculate that the genes related to low
birth weight may also regulate some of the molecules that
modulate branching tubulogenesis. Even if they are not
implicated in the pathogenesis of oligonephropathy, it is
conceivable that ureteric bud branch facilitating growth
factors may one day have therapeutic potential for this
condition and lead to the prevention of hypertension and
kidney damage in later life.
Cystic disease. Many congenital disorders lead to cyst
formation in the kidney. Insights from the in vitro cell
culture model may help elucidate the basic mechanisms
underlying cyst formation. For example, MDCK cells
grown in type I collagen in the absence of HGF form
epithelial cysts. In this model, antisense inhibition of inte-
grin a2 b1 not only perturbs HGF-induced tubulogenesis
but also MDCK cyst formation; only small cysts are ob-
served [70]. The importance of cell-matrix interactions in
cyst formation [reviewed in 76] is further demonstrated by
the observation that when MDCK, mIMCD3 or UB cells
are cultured in Matrigel, which contains a variety of matrix
proteins and tightly bound growth factors [11], the cells
proliferate into cysts even in the presence of high concen-
trations of tubulogenic growth factors (Fig. 2). Thus, cell
matrix interactions are important for cyst formation. This
idea is particularly intriguing given the hypothesis that
PKD1, a gene responsible for autosomal dominant polycys-
tic kidney disease, encodes a protein involved in extracel-
lular adhesion [77].
Tubular repair after acute injury. Repair processes in
many tissues have long been thought to bear superficial
similarities to developmental processes. The growth factors
implicated in ureteric bud branching morphogenesis in vitro
appear to play important roles in the repair and regenera-
tive process in acute tubular injury models. For example, it
has been shown that HGF [78] and heparin binding EGF
[79] expression is up-regulated in injured kidneys, and both
factors are potent inducers of in vitro tubulogenesis [15].
Furthermore, administration of exogenous HGF [80, 81],
EGF [82, 83] or IGF [84] enhances kidney recovery follow-
ing a variety of insults. All these molecules induce some
degree of morphogenesis in UB cells [16].
Another growth factor believed to be important in
wound repair is TGF-b [85]. TGF-b expression has also
Fig. 6. Potential applications of tubulogenesis research.
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been shown to be up-regulated in ischemic kidneys [86]. In
light of the finding that in the mIMCD3 cell culture model
TGF-b inhibits branching with little effect on tubulogenesis
in the presence of HGF or other branching tubulogenesis
facilitating growth factors [47], it is conceivable that in-
creased TGF-b expression is important for keeping the
regeneration process regulated by inhibiting branching.
Tubular engineering. The ultimate kidney replacement
therapy is an artificial kidney. Although the filtration
function of the kidney can be largely replaced by the
dialyzer currently used in hemodialysis, it is very difficult to
replace the reabsorptive/secretive function of kidney tubu-
lar cells. If it were possible to induce a high degree of
differentiation in cells grown into tubules in three-dimen-
sional cultures, it may be possible to develop an artificial
tubule. To what extent these in vitro tubules are function-
ally mature is still unknown. Nevertheless, this constitutes
an exciting avenue for future research.
CONCLUSIONS
Although much remains to be understood, a combination
of genetic, organ culture and cell culture approaches has
produced much recent progress in our understanding of
ureteric bud branching tubulogenesis. Based on these find-
ings, a working model for branching tubulogenesis in the
kidney has been suggested [61, 87]. In addition to the
crucial interactions between proteins on the surfaces of
mesenchymal and ureteric bud cells mediated by cell-to-cell
contact, it is likely that both branching tubulogenesis
facilitating and inhibiting soluble factors are secreted by the
metanephric mesenchyme to regulate ureteric bud branch-
ing tubulogenesis. Redundancies indicate that the absence
of any one growth factor results in no gross abnormality in
kidney development. The local and/or global balance be-
tween facilitating and inhibiting growth factors helps to
coordinate the vectorial growth of branching ureteric buds
Fig. 7. Hypothetical model of growth factor regulation in branching morphogenesis. Balance of branch-promoting growth factors (such as, HGF, EGF
receptor ligands) and branch-inhibiting factors (such as, TGF-b) regulates branching morphogenesis. At branching front (A), the ratio of
branch-promoting growth factors/branch-inhibiting growth factors is high in favor of branching tubulogenesis, while near the root (B) the opposite
occurs favoring non-branching tubulogenesis. These gradients may be global and/or local. Not shown is the critical contribution of cell-cell contact
mediated by interactions between surface proteins of metanephric mesenchyme and ureteric bud cells.
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(Fig. 7). The signals from these growth factors are trans-
mitted through receptors, mostly receptor tyrosine kinases,
that modify a variety of intracellular structures such as the
cytoskeleton and junctional proteins, which lead to changes
in cell shape and motility necessary for cell migration (Fig.
4). Growth factors also remodel cell-substratum interac-
tions by altering the expression and localization of extra-
cellular matrix proteins and their integrin receptors as well
as the balance between extracellular proteases and pro-
tease inhibitors.
Particularly important are differences in the specific
spatio-temporal expression patterns of extracellular matrix
proteins, integrins, proteases, and protease inhibitors at
branch points, tips of new branches, and mature structures
(Fig. 8). This differential spatial expression of “effectors” of
branching tubulogenesis may be coordinated by transcrip-
tional factors that fall somewhere in the broad family of
homeotic genes, which may also be responsible for the
further structural and functional segmentation of the de-
veloping nephron.
It is evident that aberrations in the function of any one of
the gene products involved in normal branching tubulogen-
esis can affect nephron number. Likewise, abnormalities in
any of the aforementioned “tubulogenic” gene products
could conceivably lead to ectatic tubules or frank cyst
formation. Methods for modulating any of these gene
products could lead to effective therapies for “oligone-
phropathy,” a condition that manifests as hypertension, and
cystic disease. Moreover, the likely overlap of epithelial
tissue development and repair makes it conceivable that
gene products regulating branching tubulogenesis can be
applied to the therapy of acute renal failure. Ultimately,
refinement of in vitro kidney tubule culture techniques may
lead to artificial tubules/kidneys. Thus, from this simple cell
culture model for in vitro branching tubulogenesis, it is not
unreasonable to expect important insights applicable to a
broad spectrum of kidney disorders.
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APPENDIX
Abbreviations used in this article are: BMP7, bone morphogenic protein
7; BSN-CM, BSN conditioned medium; EGF, epidermal growth factor;
EGFR, epidermal growth factor receptor; GDNF, glial-cell-line-derived
neurotrophic growth factor; HGF, hepatocyte growth factor; IGF, insulin-
like growth factor; MDCK, Madin-Darby canine kidney; mIMCD, murine
inner medullary collecting duct; MMP-1, matrix metalloproteinase; PI3
kinase, phosphoinositide-3 kinase; PLCg, phospholipase Cg; RT-PCR,
reverse transcription-polymerase chain reaction; TGF, transforming
growth factor; UB, ureteric bud.
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